Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Dialysis-associated hyperglycemia: manifestations and treatment.

Sun Y, Roumelioti ME, Ganta K, Glew RH, Gibb J, Vigil D, Do C, Servilla KS, Wagner B, Owen J, Rohrscheib M, Dorin RI, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2020 Mar;52(3):505-517. doi: 10.1007/s11255-019-02373-1. Epub 2020 Jan 18. Review.

PMID:
31955362
2.

Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications.

Tzamaloukas AH, Khitan ZJ, Glew RH, Roumelioti ME, Rondon-Berrios H, Elisaf MS, Raj DS, Owen J, Sun Y, Siamopoulos KC, Rohrscheib M, Ing TS, Murata GH, Shapiro JI, Malhotra D.

J Am Heart Assoc. 2019 Oct;8(19):e011786. doi: 10.1161/JAHA.118.011786. Epub 2019 Sep 24. No abstract available.

3.

Principles of quantitative water and electrolyte replacement of losses from osmotic diuresis.

Roumelioti ME, Ing TS, Rondon-Berrios H, Glew RH, Khitan ZJ, Sun Y, Malhotra D, Raj DS, Agaba EI, Murata GH, Shapiro JI, Tzamaloukas AH.

Int Urol Nephrol. 2018 Jul;50(7):1263-1270. doi: 10.1007/s11255-018-1822-0. Epub 2018 Mar 6. Review.

PMID:
29511980
4.

Fluid balance concepts in medicine: Principles and practice.

Roumelioti ME, Glew RH, Khitan ZJ, Rondon-Berrios H, Argyropoulos CP, Malhotra D, Raj DS, Agaba EI, Rohrscheib M, Murata GH, Shapiro JI, Tzamaloukas AH.

World J Nephrol. 2018 Jan 6;7(1):1-28. doi: 10.5527/wjn.v7.i1.1. Review.

5.

Reproducibility of serial creatinine excretion measurements in peritoneal dialysis.

Xu Z, Murata GH, Sun Y, Glew RH, Qualls C, Vigil D, Servilla KS, Golper TA, Tzamaloukas AH.

World J Nephrol. 2017 Jul 6;6(4):201-208. doi: 10.5527/wjn.v6.i4.201.

6.

Advanced wasting in peritoneal dialysis patients.

Xu Z, Murata GH, Glew RH, Sun Y, Vigil D, Servilla KS, Tzamaloukas AH.

World J Nephrol. 2017 May 6;6(3):143-149. doi: 10.5527/wjn.v6.i3.143.

7.

Hypertonicity: Clinical entities, manifestations and treatment.

Rondon-Berrios H, Argyropoulos C, Ing TS, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan ZJ, Murata GH, Shapiro JI, Tzamaloukas AH.

World J Nephrol. 2017 Jan 6;6(1):1-13. doi: 10.5527/wjn.v6.i1.1. Review.

8.

Hypertonicity: Pathophysiologic Concept and Experimental Studies.

Argyropoulos C, Rondon-Berrios H, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan Z, Murata GH, Shapiro JI, Tzamaloukas AH.

Cureus. 2016 May 2;8(5):e596. doi: 10.7759/cureus.596. Review.

9.

Discrepancy between Measured Serum Total Carbon Dioxide Content and Bicarbonate Concentration Calculated from Arterial Blood Gases.

Kim Y, Massie L, Murata GH, Tzamaloukas AH.

Cureus. 2015 Dec 7;7(12):e398. doi: 10.7759/cureus.398.

10.

Respiratory failure in diabetic ketoacidosis.

Konstantinov NK, Rohrscheib M, Agaba EI, Dorin RI, Murata GH, Tzamaloukas AH.

World J Diabetes. 2015 Jul 25;6(8):1009-23. doi: 10.4239/wjd.v6.i8.1009. Review.

11.

Indices of serum tonicity in clinical practice.

Rohrscheib M, Rondon-Berrios H, Argyropoulos C, Glew RH, Murata GH, Tzamaloukas AH.

Am J Med Sci. 2015 Jun;349(6):537-44. doi: 10.1097/MAJ.0000000000000470.

PMID:
26002851
12.

Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?

Tzamaloukas AH, Shapiro JI, Raj DS, Murata GH, Glew RH, Malhotra D.

Am J Med Sci. 2014 Nov;348(5):432-9. doi: 10.1097/MAJ.0000000000000331. Review.

13.

Incidence of non-severe hypoglycaemia and intensity of treatment among veterans with type 2 diabetes in the U.S.A.: a prospective observational study.

Wendel CS, Fotieo GG, Shah JH, Felicetta J, Curtis BH, Murata GH.

Diabet Med. 2014 Dec;31(12):1524-31. doi: 10.1111/dme.12543. Epub 2014 Jul 22.

PMID:
24975871
14.

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.

Campbell HM, Khan N, Raisch DW, Borrego ME, Sather MR, Murata GH.

Diabetes Res Clin Pract. 2013 Dec;102(3):233-41. doi: 10.1016/j.diabres.2013.10.005. Epub 2013 Oct 9.

PMID:
24183258
15.

Sustained remission of antineutrophil cytoplasmic antibody-mediated glomerulonephritis and nephrotic syndrome in mixed connective tissue disease.

Konstantinov KN, Harris AA, Barry M, Murata GH, Tzamaloukas AH.

J Clin Med Res. 2013 Aug;5(4):316-21. doi: 10.4021/jocmr1391w. Epub 2013 Jun 21.

16.

Principles of management of severe hyponatremia.

Tzamaloukas AH, Malhotra D, Rosen BH, Raj DS, Murata GH, Shapiro JI.

J Am Heart Assoc. 2013 Jan 23;2(1):e005199. doi: 10.1161/JAHA.112.005199. Review. No abstract available. Erratum in: J Am Heart Assoc. 2013 Aug;2(4):e000240.

17.

Surgical procedures before and after starting chronic hemodialysis in a predominantly male population with high prevalence of diabetes.

Martinez M, Last R, Agaba EI, Kassam H, Sun Y, Servilla KS, Murata GH, Tzamaloukas AH.

Int J Artif Organs. 2012 Sep;35(9):648-54. doi: 10.5301/ijao.5000120.

PMID:
23065894
18.

Influence of comorbidities and inactivity on the long-term outcomes of coronary artery bypass graft surgery in a small number of men on chronic hemodialysis.

Gabaldon D, Xhu Z, Pett SB, Sun Y, Agaba EI, Servilla KS, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2013 Feb;45(1):293-5. doi: 10.1007/s11255-012-0172-6. Epub 2012 Apr 15. No abstract available.

PMID:
22528585
19.

Hospitalizations before and after initiation of chronic hemodialysis.

Kassam H, Sun Y, Adeniyi M, Agaba EI, Martinez M, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.

Hemodial Int. 2011 Jul;15(3):341-9. doi: 10.1111/j.1542-4758.2011.00551.x. Epub 2011 May 13.

PMID:
21564504
20.

Hospital admissions in elderly patients on chronic hemodialysis.

Sun Y, Kassam H, Adeniyi M, Martinez M, Agaba EI, Onime A, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2011 Dec;43(4):1229-36. doi: 10.1007/s11255-011-9913-1. Epub 2011 Mar 2.

PMID:
21360163
21.

A system-based intervention to improve colorectal cancer screening uptake.

Hoffman RM, Steel SR, Yee EF, Massie L, Schrader RM, Moffett ML, Murata GH.

Am J Manag Care. 2011 Jan;17(1):49-55.

22.

Death during hospitalization in patients on chronic hemodialysis.

Behl M, Sun Y, Agaba EI, Martinez M, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.

Hemodial Int. 2010 Oct;14 Suppl 1:S14-21. doi: 10.1111/j.1542-4758.2010.00485.x.

PMID:
21040413
23.

Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance.

Tzamaloukas AH, Ing TS, Elisaf MS, Raj DS, Siamopoulos KC, Rohrscheib M, Murata GH.

Int Urol Nephrol. 2010 Dec;42(4):1015-22. doi: 10.1007/s11255-010-9831-7. Epub 2010 Sep 19. Review.

PMID:
20853142
24.

Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reports.

Tzamaloukas AH, Ing TS, Elisaf MS, Raj DS, Siamopoulos KC, Rohrscheib M, Murata GH.

Int Urol Nephrol. 2011 Jun;43(2):451-9. doi: 10.1007/s11255-010-9830-8. Epub 2010 Sep 9. Review.

PMID:
20827508
25.

Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease.

Cone CJ, Bachyrycz AM, Murata GH.

Ann Pharmacother. 2010 Oct;44(10):1655-9. doi: 10.1345/aph.1P099. Epub 2010 Aug 31.

PMID:
20647417
26.

Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.

Sun Y, Scavini M, Orlando RA, Murata GH, Servilla KS, Tzamaloukas AH, Schrader R, Bedrick EJ, Burge MR, Abumrad NA, Zager PG.

Diabetes Care. 2010 Sep;33(9):2065-7. doi: 10.2337/dc10-0460. Epub 2010 Jun 14.

27.

Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.

Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH.

Prev Med. 2010 May-Jun;50(5-6):297-9. doi: 10.1016/j.ypmed.2010.03.010. Epub 2010 Mar 20.

PMID:
20307568
28.

The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research.

Go AS, Magid DJ, Wells B, Sung SH, Cassidy-Bushrow AE, Greenlee RT, Langer RD, Lieu TA, Margolis KL, Masoudi FA, McNeal CJ, Murata GH, Newton KM, Novotny R, Reynolds K, Roblin DW, Smith DH, Vupputuri S, White RE, Olson J, Rumsfeld JS, Gurwitz JH.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):138-47. doi: 10.1161/CIRCOUTCOMES.108.801654.

PMID:
20031802
29.

Hospitalizations in patients treated sequentially by chronic hemodialysis and continuous peritoneal dialysis.

Adeniyi M, Kassam H, Agaba EI, Sun Y, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.

Adv Perit Dial. 2009;25:72-5.

PMID:
19886321
30.

Sources of variation in estimates of lean body mass by creatinine kinetics and by methods based on body water or body mass index in patients on continuous peritoneal dialysis.

Tzamaloukas AH, Murata GH, Piraino B, Raj DS, VanderJagt DJ, Bernardini J, Servilla KS, Sun Y, Glew RH, Oreopoulos DG.

J Ren Nutr. 2010 Mar;20(2):91-100. doi: 10.1053/j.jrn.2009.08.004. Epub 2009 Oct 22.

PMID:
19853476
31.

Blood glucose monitoring is associated with better glycemic control in type 2 diabetes: a database study.

Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM.

J Gen Intern Med. 2009 Jan;24(1):48-52. doi: 10.1007/s11606-008-0830-7. Epub 2008 Oct 31.

32.

Pathophysiology and management of fluid and electrolyte disturbances in patients on chronic dialysis with severe hyperglycemia.

Tzamaloukas AH, Ing TS, Siamopoulos KC, Raj DS, Elisaf MS, Rohrscheib M, Murata GH.

Semin Dial. 2008 Sep-Oct;21(5):431-9. doi: 10.1111/j.1525-139X.2008.00464.x. Review.

PMID:
18945331
33.

The prescription of peritoneal dialysis.

Tzamaloukas AH, Raj DS, Onime A, Servilla KS, Vanderjagt DJ, Murata GH.

Semin Dial. 2008 May-Jun;21(3):250-7. doi: 10.1111/j.1525-139X.2007.00412.x. Epub 2008 Feb 1. Review. Erratum in: Semin Dial. 2009 Mar-Apr;22(2):221.

PMID:
18248525
34.

Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: review of published reports.

Tzamaloukas AH, Ing TS, Siamopoulos KC, Rohrscheib M, Elisaf MS, Raj DS, Murata GH.

J Diabetes Complications. 2008 Jan-Feb;22(1):29-37. doi: 10.1016/j.jdiacomp.2007.06.012. Review.

PMID:
18191075
35.

Twenty-first Century ethics of medical research involving human subjects: achievements and challenges.

Tzamaloukas AH, Konstantinov KN, Agaba EI, Raj DS, Murata GH, Glew RH.

Int Urol Nephrol. 2008;40(1):153-63. doi: 10.1007/s11255-007-9319-2. Epub 2008 Jan 11. Review.

PMID:
18188674
36.

Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: theoretical analysis.

Tzamaloukas AH, Ing TS, Siamopoulos KC, Rohrscheib M, Elisaf MS, Raj DS, Murata GH.

J Diabetes Complications. 2007 Nov-Dec;21(6):374-80.

PMID:
17967710
37.
38.

Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy.

Yee EF, White RE, Murata GH, Handanos C, Hoffman RM.

J Gen Intern Med. 2007 Sep;22(9):1305-10. Epub 2007 Jul 17.

39.

Inadequacy of dialysis, chronic inflammation and malnutrition in Nigerian patients on chronic hemodialysis.

Tzamaloukas AH, Vanderjagt DJ, Agaba EI, Ma I, Lopez A, Tzamaloukas RA, Murata GH, Glew RH.

Int J Artif Organs. 2006 Nov;29(11):1067-73.

PMID:
17160964
40.
41.

Lack of precision of indirect estimates of body water affects urea kinetic analysis in chronic peritoneal dialysis.

Tzamaloukas AH, Murata GH, Vanderjagt DJ, Servilla KS, Glew RH.

Adv Perit Dial. 2005;21:13-6.

PMID:
16686277
42.

Withdrawal from dialysis: ethical issues.

Conneen S, Tzamaloukas AH, Adler K, Keller LK, Bordenave K, Murata GH.

Dial Transplant. 1998 Apr;27(4):200, 202-4.

PMID:
16370109
43.

Prevention of nephropathy in patients with type 2 diabetes mellitus.

Tzamaloukas AH, Murata GH.

Int Urol Nephrol. 2005;37(3):655-63. Review.

PMID:
16307358
44.

Reliability and validity of the DCP among hispanic veterans.

Cunningham V, Mohler MJ, Wendel CS, Hoffman RM, Murata GH, Shah JH, Duckworth WC.

Eval Health Prof. 2005 Dec;28(4):447-63.

PMID:
16272425
45.

Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations.

Dellabarca C, Servilla KS, Hart B, Murata GH, Tzamaloukas AH.

Int Urol Nephrol. 2005;37(1):171-3.

PMID:
16132782
46.

Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.

Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM.

J Diabetes Complications. 2005 Jan-Feb;19(1):10-7.

PMID:
15642485
47.

Hypoglycemia in type 2 diabetes: a critical review.

Murata GH, Duckworth WC, Hoffman RM, Wendel CS, Mohler MJ, Shah JH.

Biomed Pharmacother. 2004 Dec;58(10):551-9. Review.

PMID:
15589062
48.

Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.

Murata GH, Shah JH, Duckworth WC, Wendel CS, Mohler MJ, Hoffman RM.

J Am Diet Assoc. 2004 Dec;104(12):1816-26.

PMID:
15565075
49.
50.

Obesity and patient survival in chronic dialysis.

Tzamaloukas AH, Murata GH.

Adv Perit Dial. 2004;20:79-85. Review.

PMID:
15384801

Supplemental Content

Loading ...
Support Center